Showing results (161-170 of 261) with videos related to

Sort By:
Pageof 27
Breathe (Sheffield, England)|June 25, 2026
A hypermetabolic pulmonary lesion in a patient with breast cancerGiovanni Franco, Samuele Promi, Isabella Galbardi, et al.
Reumatismo|November 17, 2025
The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung diseaseChiara Crotti, Nicola Ughi, Carlo Alberto Scirè, et al.
Autoimmunity Reviews|September 4, 2014
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literatureClodoveo Ferri, Marco Sebastiani, Andrea Lo Monaco, et al.
BMC Pulmonary Medicine|June 20, 2018
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung diseaseGiacomo Sgalla, Simon L F Walsh, Nicola Sverzellati, et al.
Scientific Reports|April 15, 2018
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosisDavide Biondini, Elisabetta Balestro, Donato Lacedonia, et al.
Internal and Emergency Medicine|May 27, 2020
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosisElisabetta Cocconcelli, Roberto Tonelli, Gianluca Abbati, et al.
Journal of Clinical Medicine|August 14, 2020
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-AnalysisGian Luca Erre, Marco Sebastiani, Maria Antonietta Fenu, et al.
Frontiers in Oncology|November 13, 2023
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA projectMarina Elena Cazzaniga, Antonio Ciaccio, Romano Danesi, et al.
Plos One|March 12, 2015
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trialAlessia Verduri, Fabrizio Luppi, Roberto D'Amico, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung DiseasesPaola Faverio, Anna Stainer, Sara Conti, et al.
Pageof 27